Biosynthesis of dystroglycan: processing of a precursor propeptide

被引:150
作者
Holt, KH
Crosbie, RH
Venzke, DP
Campbell, KP
机构
[1] Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Physiol & Biophys, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Howard Hughes Med Inst, Dept Neurol, Iowa City, IA 52242 USA
关键词
dystroglycan; glycosylation; Chinese hamster ovary cell; dystrophin-glycoprotein complex;
D O I
10.1016/S0014-5793(00)01195-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Dystroglycan is a cytoskeleton-linked extracellular matrix receptor expressed in many cell types. Dystroglycan is composed of alpha- and beta-subunits which are encoded by a single mRNA. Using a heterologous mammalian expression system, we provide the first biochemical evidence of the alpha/beta-dystroglycan precursor propeptide prior to enzymatic cleavage. This 160 kDa dystroglycan propeptide is processed into alpha- and beta-dystroglycan (120 kDa and 43 kDa, respectively), We also demonstrate that the precursor propeptide is glycosylated and that blockade of asparagine-linked (N-linked) glycosylation did not prevent the cleavage of the dystroglycan precursor peptide. However, inhibition of N-linked glycosylation results in aberrant trafficking of the alpha- and beta-dystroglycan subunits to the plasma membrane. Thus, dystroglycan is synthesized as a precursor propeptide that is post-translationally cleaved and differentially glycosylated to yield alpha- and beta-dystroglycan. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:79 / 83
页数:5
相关论文
共 33 条
[1]   Mild congenital muscular dystrophy in two patients with an internally deleted laminin alpha 2-chain [J].
Allamand, V ;
Sunada, Y ;
Salih, MAM ;
Straub, V ;
Ozo, CO ;
AlTuraiki, MHS ;
Akbar, M ;
Kolo, T ;
Colognato, H ;
Zhang, X ;
Sorokin, LM ;
Yurchenco, PD ;
Tryggvason, K ;
Campbell, KP .
HUMAN MOLECULAR GENETICS, 1997, 6 (05) :747-752
[2]  
BRACACCIO S, 1995, FEBS LETT, V368, P139
[3]   3 MUSCULAR-DYSTROPHIES - LOSS OF CYTOSKELETON EXTRACELLULAR-MATRIX LINKAGE [J].
CAMPBELL, KP .
CELL, 1995, 80 (05) :675-679
[4]   Identification of α-dystroglycan as a receptor for lymphocytic choriomeningitis virus and lassa fever virus [J].
Cao, W ;
Henry, MD ;
Borrow, P ;
Yamada, H ;
Elder, JH ;
Ravkov, EV ;
Nichol, ST ;
Compans, RW ;
Campbell, KP ;
Oldstone, MBA .
SCIENCE, 1998, 282 (5396) :2079-2081
[5]   THE ALPHA-DYSTROGLYCAN-BETA-DYSTROGLYCAN COMPLEX - MEMBRANE ORGANIZATION AND RELATIONSHIP TO AN AGRIN RECEPTOR [J].
DEYST, KA ;
BOWE, MA ;
LESZYK, JD ;
FALLON, JR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (43) :25956-25959
[6]   Dystroglycan in development and disease [J].
Durbeej, M ;
Henry, MD ;
Campbell, KP .
CURRENT OPINION IN CELL BIOLOGY, 1998, 10 (05) :594-601
[7]   Tissue-specific heterogeneity in alpha-dystroglycan sialoglycosylation - Skeletal muscle alpha-dystroglycan is a latent receptor for Vicia villosa agglutinin B-4 masked by sialic acid modification [J].
Ervasti, JM ;
Burwell, AL ;
Geissler, AL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (35) :22315-22321
[8]   A ROLE FOR THE DYSTROPHIN-GLYCOPROTEIN COMPLEX AS A TRANSMEMBRANE LINKER BETWEEN LAMININ AND ACTIN [J].
ERVASTI, JM ;
CAMPBELL, KP .
JOURNAL OF CELL BIOLOGY, 1993, 122 (04) :809-823
[9]  
GEE SH, 1993, J BIOL CHEM, V268, P14972
[10]   MUTATIONS IN THE LAMININ ALPHA-2-CHAIN GENE (LAMA2) CAUSE MEROSIN-DEFICIENT CONGENITAL MUSCULAR-DYSTROPHY [J].
HELBLINGLECLERC, A ;
ZHANG, X ;
TOPALOGLU, H ;
CRUAUD, C ;
TESSON, F ;
WEISSENBACH, J ;
TOME, FMS ;
SCHWARTZ, K ;
FARDEAU, M ;
TRYGGVASON, K ;
GUICHENEY, P .
NATURE GENETICS, 1995, 11 (02) :216-218